Found: 186
Select item for more details and to access through your institution.
Utility of contrast-enhanced ultrasound with perflubutane for diagnosing the macroscopic type of small nodular hepatocellular carcinomas.
- Published in:
- European Radiology, 2014, v. 24, n. 9, p. 2157, doi. 10.1007/s00330-014-3254-2
- By:
- Publication type:
- Article
Metabolic dysfunction‐associated steatotic liver disease criteria may underestimate the number of lean female nonalcoholic fatty liver disease patients with significant liver fibrosis.
- Published in:
- Hepatology Research, 2024, v. 54, n. 5, p. 429, doi. 10.1111/hepr.13994
- By:
- Publication type:
- Article
Comparative analysis of the therapeutic outcomes of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma patients aged 80 years and older: Multicenter study.
- Published in:
- Hepatology Research, 2024, v. 54, n. 4, p. 382, doi. 10.1111/hepr.13991
- By:
- Publication type:
- Article
Geriatric nutritional risk index as an easy‐to‐use assessment tool for nutritional status in hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
- Published in:
- Hepatology Research, 2023, v. 53, n. 10, p. 1031, doi. 10.1111/hepr.13934
- By:
- Publication type:
- Article
Association of proton pump inhibitor and antibiotic use with the clinical outcomes of hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: A multicenter analysis.
- Published in:
- Hepatology Research, 2023, v. 53, n. 8, p. 737, doi. 10.1111/hepr.13905
- By:
- Publication type:
- Article
Clinical outcomes of antithrombin III‐based therapy for patients with portal vein thrombosis: A retrospective, multicenter study.
- Published in:
- Hepatology Research, 2023, v. 53, n. 1, p. 51, doi. 10.1111/hepr.13840
- By:
- Publication type:
- Article
Usefulness of neutrophil‐to‐lymphocyte ratio in predicting progression and survival outcomes after atezolizumab–bevacizumab treatment for hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2023, v. 53, n. 1, p. 61, doi. 10.1111/hepr.13836
- By:
- Publication type:
- Article
Diagnosis of hepatic steatosis based on ultrasound attenuation imaging is not influenced by liver fibrosis.
- Published in:
- Hepatology Research, 2022, v. 52, n. 12, p. 1009, doi. 10.1111/hepr.13831
- By:
- Publication type:
- Article
Validation of the easy‐to‐use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib.
- Published in:
- Hepatology Research, 2022, v. 52, n. 12, p. 1050, doi. 10.1111/hepr.13824
- By:
- Publication type:
- Article
Combined ultrasound and magnetic resonance elastography predict hepatocellular carcinoma after hepatitis C virus eradication.
- Published in:
- Hepatology Research, 2022, v. 52, n. 11, p. 957, doi. 10.1111/hepr.13814
- By:
- Publication type:
- Article
Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child‐Pugh class A or B liver function in real‐world clinical practice.
- Published in:
- Hepatology Research, 2022, v. 52, n. 9, p. 773, doi. 10.1111/hepr.13797
- By:
- Publication type:
- Article
Association of early bevacizumab interruption with efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: A landmark analysis.
- Published in:
- Hepatology Research, 2022, v. 52, n. 5, p. 462, doi. 10.1111/hepr.13748
- By:
- Publication type:
- Article
Time‐course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis.
- Published in:
- Hepatology Research, 2022, v. 52, n. 3, p. 235, doi. 10.1111/hepr.13739
- By:
- Publication type:
- Article
Early experience of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma BCLC‐B stage patients classified as beyond up to seven criteria – Multicenter analysis.
- Published in:
- Hepatology Research, 2022, v. 52, n. 3, p. 308, doi. 10.1111/hepr.13734
- By:
- Publication type:
- Article
Lenvatinib versus Sorafenib as first‐line treatment in hepatocellular carcinoma: A multi‐institutional matched case‐control study.
- Published in:
- Hepatology Research, 2021, v. 51, n. 12, p. 1229, doi. 10.1111/hepr.13718
- By:
- Publication type:
- Article
Therapeutic efficacy of lenvatinib as third‐line treatment after regorafenib for unresectable hepatocellular carcinoma progression.
- Published in:
- Hepatology Research, 2021, v. 51, n. 8, p. 880, doi. 10.1111/hepr.13644
- By:
- Publication type:
- Article
Association of liver stiffness and steatosis with hepatocellular carcinoma development in patients with hepatitis C virus infection who received direct‐acting antiviral therapy and achieved sustained virological response.
- Published in:
- Hepatology Research, 2021, v. 51, n. 8, p. 860, doi. 10.1111/hepr.13677
- By:
- Publication type:
- Article
Severity of liver fibrosis using shear wave elastography is influenced by hepatic necroinflammation in chronic hepatitis patients, but not in cirrhotic patients.
- Published in:
- Hepatology Research, 2021, v. 51, n. 4, p. 436, doi. 10.1111/hepr.13617
- By:
- Publication type:
- Article
Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysis.
- Published in:
- Hepatology Research, 2021, v. 51, n. 2, p. 201, doi. 10.1111/hepr.13592
- By:
- Publication type:
- Article
Attenuation imaging based on ultrasound technology for assessment of hepatic steatosis: A comparison with magnetic resonance imaging‐determined proton density fat fraction.
- Published in:
- Hepatology Research, 2020, v. 50, n. 12, p. 1319, doi. 10.1111/hepr.13563
- By:
- Publication type:
- Article
Incidence and Predictors of Esophagogastric Varices Bleeding in Patients with Hepatocellular Carcinoma in Lenvatinib.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 2, p. 215, doi. 10.1159/000534127
- By:
- Publication type:
- Article
Attempt to Establish Prognostic Predictive System for Hepatocellular Carcinoma Using Artificial Intelligence for Assistance with Selection of Treatment Modality.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 565, doi. 10.1159/000530078
- By:
- Publication type:
- Article
Relationship of Atezolizumab plus Bevacizumab Treatment with Muscle Volume Loss in Unresectable Hepatocellular Carcinoma Patients: Multicenter Analysis.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 209, doi. 10.1159/000527402
- By:
- Publication type:
- Article
Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 6, p. 527, doi. 10.1159/000525145
- By:
- Publication type:
- Article
What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 115, doi. 10.1159/000513355
- By:
- Publication type:
- Article
EZ-ALBI Score for Predicting Hepatocellular Carcinoma Prognosis.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 6, p. 734, doi. 10.1159/000508971
- By:
- Publication type:
- Article
Changes in Background Liver Function in Patients with Hepatocellular Carcinoma over 30 Years: Comparison of Child-Pugh Classification and Albumin Bilirubin Grade.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 5, p. 518, doi. 10.1159/000507933
- By:
- Publication type:
- Article
Hepatitis C Virus Cure Rates Are Reduced in Patients With Active but Not Inactive Hepatocellular Carcinoma: A Practice Implication.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 11, p. 2840, doi. 10.1093/cid/ciz1160
- By:
- Publication type:
- Article
Dynamic Evaluation of Liver Fibrosis to Assess the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis C Who Achieved Sustained Virologic Response.
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 6, p. 1208, doi. 10.1093/cid/ciz359
- By:
- Publication type:
- Article
Therapeutic efficacy of ramucirumab after lenvatinib for post-progression treatment of unresectable hepatocellular carcinoma.
- Published in:
- Gastroenterology Report, 2021, v. 9, n. 2, p. 133, doi. 10.1093/gastro/goaa042
- By:
- Publication type:
- Article
Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone?
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 14, p. 4939, doi. 10.3390/ijms21144939
- By:
- Publication type:
- Article
Response to the letter: "Predictive factors for transition to conversion therapy in HCC using atezolizumab plus bevacizumab".
- Published in:
- Liver International, 2024, v. 44, n. 7, p. 1736, doi. 10.1111/liv.15964
- By:
- Publication type:
- Article
Predictive factors for transition to conversion therapy in hepatocellular carcinoma using atezolizumab plus bevacizumab.
- Published in:
- Liver International, 2024, v. 44, n. 6, p. 1456, doi. 10.1111/liv.15907
- By:
- Publication type:
- Article
Impact of body mass index on the prognosis of unresectable HCC patients receiving first‐line Lenvatinib or atezolizumab plus bevacizumab.
- Published in:
- Liver International, 2024, v. 44, n. 5, p. 1108, doi. 10.1111/liv.15885
- By:
- Publication type:
- Article
Comparison of prognostic impact of atezolizumab plus bevacizumab versus lenvatinib in patients with intermediate‐stage hepatocellular carcinoma.
- Published in:
- Liver International, 2024, v. 44, n. 1, p. 113, doi. 10.1111/liv.15753
- By:
- Publication type:
- Article
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib.
- Published in:
- Liver International, 2021, v. 41, n. 12, p. 2997, doi. 10.1111/liv.15014
- By:
- Publication type:
- Article
Lenvatinib versus sorafenib in first‐line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysis.
- Published in:
- Liver International, 2021, v. 41, n. 6, p. 1389, doi. 10.1111/liv.14817
- By:
- Publication type:
- Article
Neutrophil‐to‐lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib.
- Published in:
- Liver International, 2020, v. 40, n. 4, p. 968, doi. 10.1111/liv.14405
- By:
- Publication type:
- Article
The impact of HCV eradication by direct‐acting antivirals on the transition of precancerous hepatic nodules to HCC: A prospective observational study.
- Published in:
- Liver International, 2019, v. 39, n. 3, p. 448, doi. 10.1111/liv.13987
- By:
- Publication type:
- Article
Impact of hepatocellular carcinoma aetiology and liver function on the benefit of surveillance: A novel approach for the adjustment of lead‐time bias.
- Published in:
- Liver International, 2018, v. 38, n. 12, p. 2260, doi. 10.1111/liv.13927
- By:
- Publication type:
- Article
Viral eradication reduces all-cause mortality in patients with chronic hepatitis C virus infection: a propensity score analysis.
- Published in:
- Liver International, 2016, v. 36, n. 6, p. 817, doi. 10.1111/liv.13071
- By:
- Publication type:
- Article
Response to 'WFA<sup>+</sup>-M2BP: a novel biomarker with diagnostic and therapeutic implications in liver diseases'.
- Published in:
- Liver International, 2016, v. 36, n. 4, p. 613, doi. 10.1111/liv.13044
- By:
- Publication type:
- Article
Long‐term prognosis of liver disease in patients with eradicated chronic hepatitis C virus: An analysis using a Markov chain model.
- Published in:
- Hepatology Research, 2020, v. 50, n. 8, p. 936, doi. 10.1111/hepr.13512
- By:
- Publication type:
- Article
Liver stiffness does not affect ultrasound‐guided attenuation coefficient measurement in the evaluation of hepatic steatosis.
- Published in:
- Hepatology Research, 2020, v. 50, n. 2, p. 190, doi. 10.1111/hepr.13442
- By:
- Publication type:
- Article
Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matching.
- Published in:
- Hepatology Research, 2020, v. 50, n. 1, p. 75, doi. 10.1111/hepr.13427
- By:
- Publication type:
- Article
Circulating microRNA‐1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2019, v. 49, n. 7, p. 810, doi. 10.1111/hepr.13338
- By:
- Publication type:
- Article
Comparison of liver stiffness assessment by transient elastography and shear wave elastography using six ultrasound devices.
- Published in:
- Hepatology Research, 2019, v. 49, n. 6, p. 676, doi. 10.1111/hepr.13319
- By:
- Publication type:
- Article
Influence of renal dysfunction on dose reduction and virologic efficacy of regimens combining ribavirin and all‐oral direct acting antivirals in patients with chronic hepatitis C virus infection.
- Published in:
- Hepatology Research, 2019, v. 49, n. 5, p. 512, doi. 10.1111/hepr.13311
- By:
- Publication type:
- Article
Efficacy and safety of ombitasvir/paritaprevir/ritonavir and ribavirin for chronic hepatitis patients infected with genotype 2a in Japan.
- Published in:
- Hepatology Research, 2019, v. 49, n. 4, p. 369, doi. 10.1111/hepr.13292
- By:
- Publication type:
- Article
Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis.
- Published in:
- Hepatology Research, 2019, v. 49, n. 1, p. 111, doi. 10.1111/hepr.13243
- By:
- Publication type:
- Article